News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  23rd September 2010  
 

IMCB Executive Director, Neal Copeland, to step down from Oct 1, 2010

 
 



From 1 October, 2010, Professor Neal Copeland will be stepping down as Executive Director of IMCB.  Prof. Copeland joined IMCB in September, 2006 with his wife and co-Principal investigator, Nancy Jenkins, before assuming the role of Executive Director in November, 2007.  After dedicating the past three years to the management and administration of IMCB, this move will offer Prof. Copeland the chance to focus on his research, as he continues to lead the Cancer Genetics Laboratory at IMCB with Prof. Jenkins.

During his term as the Executive Director, Prof. Copeland has made significant contributions to IMCB, strengthening IMCB’s basic science and reaffirming the institute’s relevance both locally and internationally. He consolidated IMCB’s research focus in areas such as cancer, cell biology, developmental biology and inflammatory diseases. Prof. Copeland also shaped the organisation of IMCB, streamlining IMCB research laboratories into four main divisions to encourage collaboration and the sharing of resources. He introduced career progression plans for the scientists, improved the mentorship of junior researchers, and recruited outstanding junior and senior level scientists. 

IMCB wishes to thank Prof. Copeland for his strong leadership over the past three years and for his considerable contributions to IMCB.

Prof. Stephen Cohen, currently Deputy Director (Strategic Planning) at IMCB, will serve as the acting Executive Director of IMCB until the new Executive Director is appointed by A*STAR.

For more information on Neal Copeland’s laboratory, please click here.

For more information on Stephen Cohenís laboratory, please click here.